glp 1 agonist drugs mechanism of action of GLP-1 agonists – My Endo Consult List of GLP-1 Receptor Agonists
Description
GLP-1RA intervention was associated with a reduction in HDL when compared to those given metformin or placebo (MD = 0.02
Both are compounded and customized to your dosing needs
Efpeglenatide Efpeglenatide is a novel, long-acting GLP-1 receptor agonist developed by Hanmi Pharmaceuticals (South Korea) utilizing the proprietary LAPSCOVERY (Long-Acting Protein/Peptide Discovery) technology platform
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al
In a pairwise meta-analysis comparing treatment adherence and persistence between GLP-1 RAs and long-acting insulin analogues, the odds ratio for non-adherence was 1.95, suggesting better adherence with the insulin analogs [174]
